1386874-06-1 (8-[5-(1-hydroxy-1-methylethyl)pyridin-3-yl]-1-[(2S)-2-methoxypropyl]-3-methyl-1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-one,Samotolisib)

CAS号:
1386874-06-1
中文名称:
8-[5-(1-hydroxy-1-methylethyl)pyridin-3-yl]-1-[(2S)-2-methoxypropyl]-3-methyl-1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-one
英文名称:
Samotolisib
分子式:
C23H26N4O3
分子量:
406.4775
简介:
Samotolisib (LY3023414) 有效且选择性地抑制 PI3Kα,PI3Kβ,PI3Kδ,PI3Kγ,DNA-PK,和 mTOR ,IC50 分别为 6.07 nM,77.6 nM,38 nM,23.8 nM,4.24 nM,和 165 nM。在低纳摩尔浓度下,Samotolisib 有效抑制 mTORC1/2。

8-[5-(1-hydroxy-1-methylethyl)pyridin-3-yl]-1-[(2S)-2-methoxypropyl]-3-methyl-1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-one(1386874-06-1)名称与标识符

名称

中文别名:
1,3-二氢-8-[5-(1-羟基-1-甲基乙基)-3-吡啶基]-1-[(2S)-2-甲氧基丙基]-3-甲基-2H-咪唑并[4,5-c]喹啉-2-酮;LY3023414;
英文别名:
8-[5-(1-hydroxy-1-methylethyl)pyridin-3-yl]-1-[(2S)-2-methoxypropyl]-3-methyl-1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-one;LY 3023414;LY-3023414;LY3023414;Samotolisib;GTPL8918;Samotolisib (USAN);Samotolisib [USAN];C88817F47Y;(S)-8-(5-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-(2-methoxypropyl)-3-methyl-1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-one;2H-Imidazo(4,5-C)quinolin-2-one, 1,3-dihydro-8-(5-(1-hydroxy-1-methylethyl)-3-pyridinyl)-1-((2S)-2-methoxypropyl)-3-methyl-;8-[5-(2-hydroxypropan-2-yl)pyridin-3-yl]-1-[(2S)-2-methoxypropyl]-3-methylimidazo[4,5-c]quinolin-2-one;example 1 [US8440829];2H;AKOS030526474;CHEMBL4297181;2H-Imidazo[4,5-c]quinolin-2-one, 1,3-dihydro-8-[5-(1-hydroxy-1-methylethyl)-3-pyridinyl]-1-[(2S)-2-methoxypropyl]-3-methyl-;example 1 (US8440829);8-(5-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((2S)-2-methoxypropyl)-3-methylimidazo(4,5-c)quinolin-2-one;8-(5-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((2S)-2-methoxypropyl)-3-methyl-1H,2H,3H-imidazo(4,5-c)quinolin-2-one;BCP16703;NS00073419;BDBM50607920;Q27082852;D11501;8-[5-(2-hydroxypropan-2-yl)pyridin-3-yl]-1-[(2S)-2-methoxypropyl]-3-methyl-1H,2H,3H-imidazo[4,5-c]quinolin-2-one;NSC800994;NSC789968;1386874-06-1;NCGC00485487-01;DB12167;ACCFLVVUVBJNGT-AWEZNQCLSA-N;Z2327235564;PI3K/MTOR INHIBITOR LY3023414;SCHEMBL10321700;NSC-800994;WHO 10889;CCG-264765;DA-75194;1,3-dihydro-8-(5-(1-hydroxy-1-methylethyl)-3-pyridinyl)-1-((2S)-2-methoxypropyl)-3-methyl-2H-imidazo(4,5-C)quinolin-2-one;AT19320;(S)-8-(5-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-(2-methoxypropyl)-3-methyl-1H-imidazo[4,5-c]quinolin-2(3H)-one;HY-12513;UNII-C88817F47Y;EX-A2728;8-(5-(2-HYDROXYPROPAN-2-YL)PYRIDIN-3-YL)-1-((2S)-2-METHOXYPROPYL)-3-METHYL-1,3-DIHYDRO-2H-IMIDAZO(4,5-C)QUINOLIN-2-ONE;8-[5-(2-Hydroxypropan-2-yl)pyridin-3-yl]-1-[(2S)-2-methoxypropyl]-3-methyl-1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-one;NSC-789968;BRD-K82967180-001-01-6;s8322;AC-30224;SAMOTOLISIB [INN];CS-5361;SAMOTOLISIB [WHO-DD];

标识符

MDL:
MFCD28411368
InChIKey:
ACCFLVVUVBJNGT-AWEZNQCLSA-N
Inchi:
1S/C23H26N4O3/c1-14(30-5)13-27-21-18-9-15(16-8-17(11-24-10-16)23(2,3)29)6-7-19(18)25-12-20(21)26(4)22(27)28/h6-12,14,29H,13H2,1-5H3/t14-/m0/s1
SMILES:
O(C([H])([H])[H])[C@@]([H])(C([H])([H])[H])C([H])([H])N1C(N(C([H])([H])[H])C2=C([H])N=C3C([H])=C([H])C(C4C([H])=NC([H])=C(C=4[H])C(C([H])([H])[H])(C([H])([H])[H])O[H])=C([H])C3=C12)=O

8-[5-(1-hydroxy-1-methylethyl)pyridin-3-yl]-1-[(2S)-2-methoxypropyl]-3-methyl-1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-one(1386874-06-1)物化性质

实验特性

  • 溶解度 : Very 微溶 (0.12 g/L) (25 ºC),
  • 密度 : 1.239±0.06 g/cm3 (20 ºC 760 Torr),

计算特性

  • 精确分子量 : 406.200491g/mol
  • 氢键供体数量 : 1
  • 氢键受体数量 : 5
  • 可旋转化学键数量 : 5
  • 同位素质量 : 406.200491g/mol
  • 重原子数量 : 30
  • 复杂度 : 630
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 1
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 1.7
  • 拓扑分子极性表面积 : 78.8
  • 分子量 : 406.5g/mol

8-[5-(1-hydroxy-1-methylethyl)pyridin-3-yl]-1-[(2S)-2-methoxypropyl]-3-methyl-1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-one(1386874-06-1)安全信息

8-[5-(1-hydroxy-1-methylethyl)pyridin-3-yl]-1-[(2S)-2-methoxypropyl]-3-methyl-1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-one(1386874-06-1)推荐厂家 更多厂家(16)